251
Views
25
CrossRef citations to date
0
Altmetric
Review

Clinical Utility Of The Exhaled Nitric Oxide (NO) Measurement With Portable Devices In The Management Of Allergic Airway Inflammation And Asthma

ORCID Icon
Pages 331-341 | Published online: 07 Oct 2019

References

  • Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993;6:1368–1370.7507065
  • Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=exhaled+nitric+oxide++and+asthma. Accessed 12:55 PM; 720, 2019.
  • American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160:2104–2117. doi:10.1164/ajrccm.160.6.ats8-9910588636
  • American Thoracic Society/European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171:912–930. doi:10.1164/rccm.200406-710ST15817806
  • Dweik RA, Boggs PB, Erzurum SC, et al. American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for clinical applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–615. doi:10.1164/rccm.9120-11ST21885636
  • Dinh-Xuan AT, Annesi-Maesano I, Berger P, et al. French Speaking Respiratory Society. Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory Society. Rev Mal Respir. 2015;32:193–215. doi:10.1016/j.rmr.2014.11.00425704902
  • Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol. 2004;114:1241–1256. doi:10.1016/j.jaci.2004.08.04215536442
  • Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res. 2006;7:67. doi:10.1186/1465-9921-7-6716626491
  • Gratziou C, Rovina N, Makris M, Simoes DC, Papapetropoulos A, Roussos C. Breath markers of oxidative stress and airway inflammation in seasonal allergic rhinitis. Int J Immunopathol Pharmacol. 2008;21:949–957. doi:10.1177/03946320080210041919144280
  • Duong-Quy S, Vu-Minh T, Hua-Huy T, et al. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma. J Asthma Allergy. 2017;10:75–82. doi:10.2147/JAA.S12904728356764
  • Deykin A, Halpern O, Massaro AF, Drazen JM, Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med. 1998;157:769–775. doi:10.1164/ajrccm.157.3.97071149517589
  • Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J. 2003;21:433–438. doi:10.1183/09031936.03.00066903a12661997
  • Nguyen-Thi-Bich H, Duong-Thi-Ly H, Thom VT, et al. Study of the correlations between fractional exhaled nitric oxide in exhaled breath and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children. J Asthma Allergy. 2016;9:163–170. doi:10.2147/JAA.S10777327695350
  • Duong-Quy S, Nguyen-Thi-Bich H, Le-Thi-Minh H, Craig T. The use of exhaled nitric oxide (NO) to categorize asthma phenotype and treatment in children-Results from National Hospital of Pediatrics. Eur Respir J. 2018;52(suppl 62):PA1315. doi:10.1183/13993003.01675-2018
  • Wen YS, Lin CY, Yang KD, Hung CH, Chang YJ, Tsai YG. Nasal nitric oxide is a useful biomarker for acute unilateral maxillary sinusitis in pediatric allergic rhinitis: a prospective observational cohort study. World Allergy Organ J. 2019;12(4):100027. doi:10.1016/j.waojou.2019.10002731193296
  • Duong-Quy S, Tran Van H, Vo Thi Kim A, Pham HQ, Craig TJ. Clinical and functional characteristics of subjects with asthma, COPD, and asthma-COPD overlap: a multicentre study in vietnam. Can Respir J. 2018;1(2018):1732946.
  • Duong-Quy S, Hua-Huy T, Tran-Mai-Thi HT, Le-Dong NN, Craig TJ, Dinh-Xuan AT. Study of exhaled nitric oxide in subjects with suspected obstructive sleep apnea: a pilot study in vietnam. Pulm Med. 2016;2016:3050918. doi:10.1155/2016/305091826881073
  • Belvisi MG, Ward JK, Mitchell JA, Barnes PJ. Nitric oxide as a neurotransmitter in human airways. Arch Int Pharmacodyn Ther. 1995;329:97.7639623
  • Jain B, Rubinstein I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun. 1993;191:83. doi:10.1006/bbrc.1993.11877680560
  • Belvisi MG, Stretton CD, Yacoub M, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol. 1992;210:221. doi:10.1016/0014-2999(92)90676-U1350993
  • Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995;1:370–373. doi:10.1038/nm1295-12577585069
  • Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993;9:371–377. doi:10.1165/ajrcmb/9.4.3717691109
  • Hyde RW, Geigel EJ, Olszowka AJ, et al. Determination of production of nitric oxide by lower airways of humans–theory. J Appl Physiol (1985). 1997;82:1290. doi:10.1152/jappl.1997.82.4.12909104867
  • Paraskakis E, Brindicci C, Fleming L, et al. Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med. 2006;174:260. doi:10.1164/rccm.200510-1659PP16627868
  • Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA. 1995;92:7809–7813. doi:10.1073/pnas.92.17.78097544004
  • Donnelly LE, Barnes PJ. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am J Respir Cell Mol Biol. 2002;26:144–151. doi:10.1165/ajrcmb.26.1.447711751214
  • Lane C, Knight D, Burgess S, et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax. 2004;59:757–760. doi:10.1136/thx.2003.01489415333851
  • Silvestri M, Spallarossa D, Frangova Yourukova V, et al. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. Eur Respir J. 1999;13:321–326. doi:10.1034/j.1399-3003.1999.13b17.x10065675
  • Ihre E, Gyllfors P, Gustafsson LE, et al. Early rise in exhaled nitric oxide and mast cell activation in repeated lowdose allergen challenge. Eur Respir J. 2006;27:1152–1159. doi:10.1183/09031936.06.0014290516510451
  • Dweik RA, Comhair SA, Gaston B, et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA. 2001;98:2622–2627. doi:10.1073/pnas.05162949811226289
  • Erpenbeck VJ, Jorres RA, Discher M, et al. Local nitric oxide levels reflect the degree of allergic airway inflammation after segmental allergen challenge in asthmatics. Nitric Oxide. 2005;13:125–133. doi:10.1016/j.niox.2005.05.00816006159
  • Guo FH, Comhair SA, Zheng S, et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol. 2000;164:5970–5980. doi:10.4049/jimmunol.164.11.597010820280
  • Hämäläinen M, Lilja R, Kankaanranta H, Moilanen E. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors. Pulm Pharmacol Ther. 2008;21(2):331–339. doi:10.1016/j.pupt.2007.08.00317913526
  • Sade K, Schwartz I, Schwartz D, et al. Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice. Clin Exp Allergy. 2003;33(12):1741–1746. doi:10.1111/j.1365-2222.2003.01798.x14656364
  • Baraldi E, Scollo M, Zaramella C, Zanconato S, Zacchello F. A simple flow-driven method for online measurement of exhaledNOstarting at the age of 4 to 5 years. Am J Respir Crit Care Med. 2000;162:1828–1832. doi:10.1164/ajrccm.162.5.200201411069821
  • Bates CA, Silkoff PE. Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol. 2003;111:256–262. doi:10.1067/mai.2003.10312589342
  • Spahn JD, Malka J, Szefler SJ. Current application of exhaled nitric oxide in clinical practice. J Allergy Clin Immunol. 2016;138:1296–1298. doi:10.1016/j.jaci.2016.09.00227664377
  • Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: comparison with the “gold standard” technique. Chest. 2007;131:410–414. doi:10.1378/chest.06-133517296641
  • Wojtas J. Application of cavity enhanced absorption spectroscopy to the detection of nitric oxide, carbonyl sulphide, and ethane—breath biomarkers of serious diseases. Sensors (Basel). 2015;15(6):14356–14369. doi:10.3390/s15061435626091398
  • Maniscalco M, Vitale C, Vatrella A, Molino A, Bianco A, Mazzarella G. Fractional exhaled nitric oxide-measuring devices: technology update. Med Devices (Auckl). 2016;9:151–160.27382340
  • Henderson B, Khodabakhsh A, Metsälä M, et al. Laser spectroscopy for breath analysis: towards clinical implementation. Appl Phys B. 2018;124(8):161. doi:10.1007/s00340-018-7030-x30956412
  • Available from: http://pdf.medicalexpo.com/pdf/aerocrine/niox-mino-brochure/85229-103071.html. Accessed 515th, 2019.
  • Available from: https://www.niox.com/en/niox-vero/about-niox-vero/. Accessed 515th, 2019.
  • Horváth I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49(4). doi:10.1183/13993003.00965-2016.
  • Khalili B, Boggs PB, Bs L. Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy. 2007;62:1171–1174. doi:10.1111/j.1398-9995.2007.01456.x17845587
  • McGill C, Malik G, Turner SW. Validation of a hand-held exhaled nitric oxide analyzer for use in children. Pediatr Pulmonol. 2006;41:1053–1057. doi:10.1002/(ISSN)1099-049616871592
  • Kissoon N, Duckworth LJ, Blake KV, et al. Exhaled nitric oxide concentrations: online versus offline values in healthy children. Pediatr Pulmonol. 2002;33:283–292. doi:10.1002/(ISSN)1099-049611921458
  • Kissoon N, Duckworth LJ, Blake KV, Murphy SP, Taylor CL, Silkoff PE. Fe(NO): relationship to exhalation rates and online versus bag collection in healthy adolescents. Am J Respir Crit Care Med. 2000;162:539–545. doi:10.1164/ajrccm.162.2.990912410934084
  • Schiller B, Hammer J, Barben J, Trachsel D. Comparability of a hand-held nitric oxide analyser with online and offline chemiluminescence-based nitric oxide measurement. Pediatr Allergy Immunol. 2009;20(7):679–685. doi:10.1111/j.1399-3038.2009.00853.x19682277
  • Menou A, Babeanu D, Paruit HN, Ordureau A, Guillard S, Chambellan A. Normal values of offline exhaled and nasal nitric oxide in healthy children and teens using chemiluminescence. J Breath Res. 2017;11(3):036008. doi:10.1088/1752-7163/aa76ef28579561
  • Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008;7:827–840. doi:10.1038/nrd266018827826
  • Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med. 2007;204:1837–1847. doi:10.1084/jem.2007040617635955
  • Lundberg JO, Weitzberg E. Nasal nitric oxide in man. Thorax. 1999;54:947–952. doi:10.1136/thx.54.5.43910491460
  • Maniscalco M, de Laurentiis G, Weitzberg E, Lundberg JO, Sofia M. Validation study of nasal nitric oxide measurements using a hand-held electrochemical analyser. Eur J Clin Invest. 2008;38:197–200. doi:10.1111/eci.2008.38.issue-318257783
  • Qian W, Djupesland PG, Chatkin JM, et al. Aspiration flow optimized for nasal nitric oxide measurement. Rhinology. 1999;37:61–65.10416250
  • Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy. 2006;61:717–724. doi:10.1111/all.2006.61.issue-616677241
  • Palm JP, Graf P, Lundberg JO, Alving K. Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements. Eur Respir J. 2000;16:236–241. doi:10.1034/j.1399-3003.2000.16b09.x10968497
  • Santos CB, Pratt EL, Hanks C, McCann J, Craig TJ. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol. 2006;97(5):579–587. doi:10.1016/S1081-1206(10)60969-617165263
  • Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. Laryngoscope. 2011;121:1830–1833. doi:10.1002/lary.2203421997726
  • Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(Suppl 85):17–25. doi:10.1111/j.1398-9995.2007.01549.x
  • Kawamoto H, Takeno S, Yajin K. Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with allergic rhinitis. Laryngoscope. 1999;109:2015–2020. doi:10.1097/00005537-199912000-0002310591366
  • Kawamoto H, Takumida M, Takeno S, et al. Localization of nitric oxide synthase in human nasal mucosa with nasal allergy. Acta Otolaryngol Suppl. 1998;539:65–70. doi:10.1080/0001648985018216110095865
  • Nesic VS, Djordjevic VZ, Tomic-Spiric V, Dudvarski ZR, Soldatovic IA, Arsovic NA. Measuring nasal nitric oxide in allergic rhinitis patients. J Laryngol Otol. 2016;130(11):1064–1071. doi:10.1017/S002221511600908727823578
  • Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997;10:1683–1693. doi:10.1183/09031936.97.100716839230267
  • Liu D, Huang Z, Huang Y, Yi X, Chen X. Measurement of nasal and fractional exhaled nitric oxide in children with upper airway inflammatory disease: preliminary results. Int J Pediatr Otorhinolaryngol. 2015;79(12):2308–2311. doi:10.1016/j.ijporl.2015.10.03326602553
  • Takeno S, Okabayashi Y, Kohno T, Yumii K, Hirakawa K. The role of nasal fractional exhaled nitric oxide as an objective parameter independent of nasal airflow resistance in the diagnosis of allergic rhinitis. Auris Nasus Larynx. 2016;44(4):S0385-8146(16)30369–8.
  • Scadding G, Scadding GK. Update on the use of nitric oxide as a noninvasive measure of airways inflammation. Rhinology. 2009;47(2):115–120.19593964
  • Cho WS, Kim TH, Kim KH, et al. Increased expression of arginase I and II in allergic nasal mucosa. Laryngoscope. 2011;121(2):236–240. doi:10.1002/lary.2128821271567
  • Bautista AP, Eisenlohr CP, Lanz MJ. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis. Am J Rhinol Allergy. 2011;25(6):383–387. doi:10.2500/ajra.2011.25.366822185740
  • Irander K, Palm JP, Borres MP, Ghafouri B. Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis. Clin Mol Allergy. 2012;6(10):4. doi:10.1186/1476-7961-10-4
  • Prado CM, Martins MA, Tibério IF. Nitric oxide in asthma physiopathology. ISRN Allergy. 2011;2011:832560.23724233
  • Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91–95 91. doi:10.1136/thx.53.2.919624291
  • Berkman N, Avital A, Breuer R, Bardach E, Springer C, Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax. 2005;60(5):383–388. doi:10.1136/thx.2004.03110415860713
  • Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest. 2003;123:751–756. doi:10.1378/chest.123.3_suppl.424s12628874
  • Global strategy for asthma management and prevention (GINA); 2019 Available from: www.ginasthma.org. Accessed 616th, 2019.
  • Silvestri M, Sabatini F, Sale R, et al. Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals. Pediatr Pulmonol. 2003;35(5):358–363. doi:10.1002/ppul.1026412687592
  • Sippel JM, Holden WE, Tilles SA, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol. 2000;106(4):645–650. doi:10.1067/mai.2000.10961811031334
  • Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004;169(4):473–478. doi:10.1164/rccm.200310-1376OC14644933
  • Syk J, Malinovschi A, Johansson G, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1(6):639–648. doi:10.1016/j.jaip.2013.07.01324565712
  • Beck-Ripp J, Griese M, Arenz S, Köring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J. 2002;19(6):1015–1019. doi:10.1183/09031936.02.0158200112108850
  • Smith AD, Cowan JO, Brassett KP, Herbison P, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163–2173. doi:10.1056/NEJMoa04359615914548
  • Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med. 1999;160:1227–1231. doi:10.1164/ajrccm.160.4.990300410508811
  • Medrek SK, Parulekar AD, Hanania NA. Predictive biomarkers for asthma therapy. Curr Allergy Asthma Rep. 2017;17(10):69. doi:10.1007/s11882-017-0739-528929293
  • Diamant Z, Vijverberg S, Alving K, et al. Towards clinically applicable biomarkers for asthma - An EAACI position paper. Allergy. 2019. doi:10.1111/all
  • Knuffman JE, Sorkness CA, Lemanske RF, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol. 2009;123:411–416. doi:10.1016/j.jaci.2008.11.01619121860
  • Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy. 2009;39(4):478–490. doi:10.1111/j.1365-2222.2009.03226.x19260871
  • Duong-Quy S, Doan-Thi-Quynh N, Tran-Thanh D, et al. The cost and benefits of exhaled nitric oxide (NO) measurement in asthma-The results from three years follow-up study. Eur Respir J. 2018;52(suppl 62):PA5499. doi:10.1183/13993003.01675-2018
  • Straub DA, Minocchieri S, Moeller A, Hamacher J, Wildhaber JH. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest. 2005;127:509–514. doi:10.1378/chest.127.2.50915705989
  • Whelan GJ, Blake K, Kissoon N, et al. Effect of montelukast on time-course of exhaled nitric oxide in asthma: influence of LTC4 synthase A(−444)C polymorphism. Pediatr Pulmonol. 2003;36:413–420. doi:10.1002/ppul.1038514520724
  • Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3:290–300. doi:10.1016/S2213-2600(15)00050-825801413
  • Fahy JV. Type 2 inflammation in asthma–present in most, absent in many. Nat Rev Immunol. 2015;15:57–65. doi:10.1038/nri378625534623
  • Haccuria A, Michils A, Michiels S, Van Muylem A. Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes. J Allergy Clin Immunol. 2014;134:554–559. doi:10.1016/j.jaci.2013.12.107024522091